Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAI Oxaliplatin for Unresectable Colorectal Liver Metastases
NCT00244348Phase 2Withdrawn
- Sponsor
- Medical College of Wisconsin
- Start
- Oct 2005
- Primary completion
- Aug 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in colorectal cancer (CRC), sponsored by Medical College of Wisconsin. Planned start Oct 2005; status: withdrawn.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00244348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244348.